Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Net Margin: 2024-2025

Historic Net Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -357.19%.

  • Kura Oncology's Net Margin fell 1356204.00% to -357.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -431.95%, marking a year-over-year change of. This contributed to the annual value of -322.89% for FY2024, which is 1017641.00% down from last year.
  • Kura Oncology's Net Margin amounted to -357.19% in Q3 2025, which was up 17.42% from -432.51% recorded in Q2 2025.
  • Kura Oncology's Net Margin's 5-year high stood at 13,204.85% during Q3 2024, with a 5-year trough of -432.51% in Q2 2025.
  • Moreover, its 2-year median value for Net Margin was 4,267.74% (2024), whereas its average is 5,891.53%.
  • Data for Kura Oncology's Net Margin shows a maximum YoY slumped of 1,356,204bps (in 2025) over the last 5 years.
  • Kura Oncology's Net Margin (Quarterly) stood at 4,267.74% in 2024, then crashed by 1,356,204bps to -357.19% in 2025.
  • Its Net Margin was -357.19% in Q3 2025, compared to -432.51% in Q2 2025 and -407.07% in Q1 2025.